MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/neuonc/noag237

Медицинская библиотека · Neuro-oncology · 2026

SNP rs2853669 potentially elevates the risk of glioblastoma development and leads to worse prognosis when in cis with mutant TERT promoter in a Japanese cohort.

Kawauchi Daisuke, Miyake Yohei, Taylor Brett, Bendik Joseph, Miki Shunichiro, Honda-Kitahara Mai, Barnholtz-Sloan Jill, Nakano Tomoyuki, Pham Philip, Vadla Raghavendra, Jones Brandon M, Wang Clark, Patel Sejal, Narita Yoshitaka, Furnari Frank

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Mutations in the telomerase reverse transcriptase (TERT) promoter region (TPM), particularly C228T and C250T, are common in IDH-wildtype glioblastoma (GBM). The single nucleotide polymorphism (SNP) rs2853669, also located in the TERT promoter, may influence telomerase activity, though its clinical relevance in GBM remains unclear. This study examined the allelic configuration between rs2853669 and TPM to elucidate their combined effects on TERT expression and clinical outcome.

METHODS

Seventy-six TPM-positive GBM tumors from Japanese patients were analyzed by nested PCR, and patients were classified by rs2853669 genotype (T/T, T/C, C/C). In the T/C subgroup, the allelic configuration between the SNP and TPM was determined as cis (same allele) or trans (different alleles). Clinical data, TERT expression, and prognosis were compared among groups.

RESULTS

Among 76 patients, 37 (48.7%) had T/T, 30 (39.5%) had T/C, and 9 (11.8%) had C/C genotypes. The rs2853669 C allele frequency was higher in GBM than in the general Japanese population (31.6% vs 24.5%, p = 0.047). Among T/C cases, 53.3% showed a cis configuration. Patients carrying the SNP and TPM on the same allele (C/C and T/C cis) had shorter overall survival than those carrying them on different alleles (T/T or T/C trans; 19 vs 25 months, p = 0.048), and TERT expression was also lower in this group (p = 0.038).

CONCLUSION

The rs2853669 C allele may increase GBM susceptibility and, when in cis with TPM, is associated with reduced TERT expression and poorer prognosis, underscoring its biological and clinical significance in TPM-mutant GBM.

Для цитирования: Kawauchi Daisuke, Miyake Yohei, Taylor Brett, Bendik Joseph, Miki Shunichiro, Honda-Kitahara Mai, Barnholtz-Sloan Jill, Nakano Tomoyuki, Pham Philip, Vadla Raghavendra, Jones Brandon M, Wang Clark, Patel Sejal, Narita Yoshitaka, Furnari Frank. SNP rs2853669 potentially elevates the risk of glioblastoma development and leads to worse prognosis when in cis with mutant TERT promoter in a Japanese cohort.. Neuro-oncology. 2026. DOI: 10.1093/neuonc/noag237.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.